×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
08:06 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
Low
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
12/3
07:00 am
nrxp
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
Medium
Report
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
12/2
07:07 pm
nrxp
NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date [Yahoo! Finance]
12/2
11:27 am
nrxp
NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript [Seeking Alpha]
Medium
Report
NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript [Seeking Alpha]
12/2
10:40 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $34.00 price target on the stock.
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $34.00 price target on the stock.
12/2
08:30 am
nrxp
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
High
Report
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
12/2
07:30 am
nrxp
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
High
Report
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
12/1
08:52 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2025
04:32 pm
NRXP
nrx pharmaceuticals, inc.
MISS
Report
-13.2%
nrx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/26
04:31 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Nov 20
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Nov 20
11/21
04:32 pm
nrxp
Form 8-K/A NRX Pharmaceuticals, For: Sep 08
Medium
Report
Form 8-K/A NRX Pharmaceuticals, For: Sep 08
11/14
04:41 pm
nrxp
Form 10-Q NRX Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q NRX Pharmaceuticals, For: Sep 30
10/23
04:31 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Oct 17
Low
Report
Form 8-K NRX Pharmaceuticals, For: Oct 17
9/26
08:01 am
nrxp
Form 8-K NRX Pharmaceuticals, For: Sep 24
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Sep 24
9/12
04:34 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Sep 08
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Sep 08
9/10
03:36 pm
nrxp
Form 4 NRX Pharmaceuticals, For: Apr 09 Filed by: Javitt Jonathan C
Low
Report
Form 4 NRX Pharmaceuticals, For: Apr 09 Filed by: Javitt Jonathan C
9/10
03:35 pm
nrxp
Form 4 NRX Pharmaceuticals, For: Apr 09 Filed by: Hurvitz Chaim
Low
Report
Form 4 NRX Pharmaceuticals, For: Apr 09 Filed by: Hurvitz Chaim
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: